-
Mashup Score: 17
Tisotumab vedotin-tftv may now be given to patients with recurrent or metastatic cervical cancer, according to the FDA.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Investigators found that imatinib maintenance therapy for 6 years reduced the risk of recurrence in patients with gastrointestinal stromal tumors.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Phase 2 data support the use of fuzuloparib with or without apatinib in HER2-negative metastatic breast cancer harboring BRCA1/2 germline mutations.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 42
The Oncology Brothers are joined by Nina Sanford, MD; Jeffrey M. Ryckman, MD; and Harris Chengazi, MD, to discuss the treatment of patients with hepatocellular carcinoma from a multidisciplinary perspective, focusing on radiation oncology and interventional radiology.
Source: www.cancernetwork.comCategories: General Medicine News, Partners & KOLsTweet-
#GISeries: Where are the #RadOnc & #IRad? Here they are… Importance of collaboration/MultiD in #gism w/@NiuSanford @jryckman3 @ChengaziMD Full 🗣️ - https://t.co/Y91X31huP6 - https://t.co/qmX0AGenEx - Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter @CancerNetwrk https://t.co/iOCegh3i0G https://t.co/EySnQWSKyN
-
-
Mashup Score: 0
Christine Bestvina, MD, presents a case of a 34-year-old non-smoker diagnosed with Stage IIIA NSCLC after presenting with chest wall pain; the panel then explores their approaches to managing toxicities, including rashes and sores, by employing dose reductions and steroids to control adverse reactions.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 41
The Oncology Brothers are joined by Nina Sanford, MD; Jeffrey M. Ryckman, MD; and Harris Chengazi, MD, to discuss the treatment of patients with hepatocellular carcinoma from a multidisciplinary perspective, focusing on radiation oncology and interventional radiology.
Source: www.cancernetwork.comCategories: General Medicine News, Partners & KOLsTweet-
#GISeries: Where are the #RadOnc & #IRad? Here they are… Importance of collaboration/MultiD in #gism w/@NiuSanford @jryckman3 @ChengaziMD Full 🗣️ - https://t.co/Y91X31huP6 - https://t.co/qmX0AGenEx - Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter @CancerNetwrk https://t.co/iOCegh3i0G https://t.co/EySnQWSKyN
-
-
Mashup Score: 3Manuscript Guidelines | Oncology Journal - 3 day(s) ago
Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The primary end point of overall survival was met in the KEYNOTE-811 trial assessing pembrolizumab in HER2-positive gastrointestinal cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
All patients with a response to TAR-200 did not have progression to muscle-invasive bladder cancer or metastatic disease in the SunRISe-1 trial.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
Data from the phase 1/2 eNRGy trial support the biologics license application for zenocutuzumab in NRG1-positive NSCLC and PDAC.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
.@US_FDA approves tisotumab vedotin-tftv for patients with recurrent/metastatic cervical cancer following previous chemotherapy. #gyncsm | @FDAOncology https://t.co/QPs4ebfiRj